Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Renal Drug Handbook, fifth edition
Product / population
Historical 2019 reference; renal bands retain the book's own method labels.
Renal method
Not specified
Source revision
Not established
Retrieved
2026-09-05
Local review status
Historical handbook facts locally summarized; not a current U.S. label or a modern CRRT protocol.
Handbook
Renal Drug Handbook, fifth edition
UK Renal Pharmacy Group / Ashley and Dunleavy / CRC Press · Historical 2019 reference; renal bands retain the book's own method labels.
Renal method: Not specified in this summary. Source date: Not established Retrieved: 2026-09-05
Historical handbook facts locally summarized; not a current U.S. label or a modern CRRT protocol.
Renal-function and dialysis summary
The book retains normal dosing at GFR 20-50, 10-20 and <10 mL/min and for APD/CAPD, HD, high-flux HDF and CAV/VVHD. Removal is described as absent for APD/CAPD and HD, and unknown for high-flux HDF and CAV/VVHD.
pantoprazole-oral:rdh5-766-1 · Source locator: Dose in renal impairment; Dose in renal replacement
Source-specific limits
The book covers both oral and IV products. This page is reconciled only to the selected U.S. oral delayed-release label; IV reconstitution, infusion and stability instructions were not transferred.
Source identity and provenance
Retrieved
2026-09-05
Handbook page
Printed page 766; PDF page 785
Hash meaning
Locally authored source summary, not original SPL/XML/PDF bytes
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.